Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Wolff

Showing results (861-870 of 973) with videos related to

Pageof 98
Sort By:
The Oncologist|April 4, 2020
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative GroupHumaid O Al-Shamsi, Waleed Alhazzani, Ahmad Alhuraiji, et al.
Molecular Cancer Therapeutics|October 5, 2013
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutationsPrasanth Ganesan, Filip Janku, Aung Naing, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancerC H Crane, N A Janjan, J L Abbruzzese, et al.
Annals of Surgical Oncology|March 22, 2001
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival durationT M Breslin, K R Hess, D B Harbison, et al.
Oncotarget|April 23, 2021
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenibYehia I Mohamed, Sunyoung Lee, Lianchun Xiao, et al.
Neuro-Oncology|September 27, 2008
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapyStefan Rutkowski, Nicolas Ulrich Gerber, Katja von Hoff, et al.
The American Journal of Surgical Pathology|February 6, 2023
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyAaron J Sohn, Mehran Taherian, Matthew H G Katz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic headDouglas B Evans, Gauri R Varadhachary, Christopher H Crane, et al.
Annals of Surgical Oncology|February 6, 2009
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinomaMatthew H G Katz, Huamin Wang, Jason B Fleming, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative ChemoradiationSunil Krishnan, Awalpreet S Chadha, Yelin Suh, et al.
Pageof 98

Showing results (861-870 of 973) with videos related to

Sort By:
Pageof 98
The Oncologist|April 4, 2020
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative GroupHumaid O Al-Shamsi, Waleed Alhazzani, Ahmad Alhuraiji, et al.
Molecular Cancer Therapeutics|October 5, 2013
Target-based therapeutic matching in early-phase clinical trials in patients with advanced colorectal cancer and PIK3CA mutationsPrasanth Ganesan, Filip Janku, Aung Naing, et al.
International Journal of Radiation Oncology, Biology, Physics|February 13, 2001
Effective pelvic symptom control using initial chemoradiation without colostomy in metastatic rectal cancerC H Crane, N A Janjan, J L Abbruzzese, et al.
Annals of Surgical Oncology|March 22, 2001
Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: treatment variables and survival durationT M Breslin, K R Hess, D B Harbison, et al.
Oncotarget|April 23, 2021
Insulin-like growth factor 1/Child-Turcotte-Pugh composite score as a predictor of treatment outcomes in patients with advanced hepatocellular carcinoma treated with sorafenibYehia I Mohamed, Sunyoung Lee, Lianchun Xiao, et al.
Neuro-Oncology|September 27, 2008
Treatment of early childhood medulloblastoma by postoperative chemotherapy and deferred radiotherapyStefan Rutkowski, Nicolas Ulrich Gerber, Katja von Hoff, et al.
The American Journal of Surgical Pathology|February 6, 2023
Integrated Pathologic Score Effectively Stratifies Patients With Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and PancreaticoduodenectomyAaron J Sohn, Mehran Taherian, Matthew H G Katz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2008
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic headDouglas B Evans, Gauri R Varadhachary, Christopher H Crane, et al.
Annals of Surgical Oncology|February 6, 2009
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinomaMatthew H G Katz, Huamin Wang, Jason B Fleming, et al.
International Journal of Radiation Oncology, Biology, Physics|March 15, 2016
Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative ChemoradiationSunil Krishnan, Awalpreet S Chadha, Yelin Suh, et al.
Pageof 98